{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:27:19Z","timestamp":1740126439289,"version":"3.37.3"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s10354-022-00999-y","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T09:03:14Z","timestamp":1674637394000},"page":"276-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Netherton syndrome in a\u00a0Bulgarian patient","Netherton-Syndrom bei einer bulgarischen Patientin"],"prefix":"10.1007","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1768-8601","authenticated-orcid":false,"given":"Simona Atanasova","family":"Kordeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilia","family":"Batashki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgi","family":"Tchernev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"issue":"7","key":"999_CR1","doi-asserted-by":"publisher","first-page":"e3070","DOI":"10.7759\/cureus.3070","volume":"10","author":"HMK Saleem","year":"2018","unstructured":"Saleem\u00a0HMK, Shahid\u00a0MF, Shahbaz\u00a0A, Sohail\u00a0A, Shahid\u00a0MA, Sachmechi\u00a0I. Netherton syndrome: A case report and review of literature. Cureus. 2018;10(7):e3070. https:\/\/doi.org\/10.7759\/cureus.3070.","journal-title":"Cureus"},{"key":"999_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1001\/archderm.1964.01590250052010","volume":"89","author":"RD Wilkinson","year":"1964","unstructured":"Wilkinson\u00a0RD, Curtis\u00a0GH, Hawk\u00a0WA. Netherton\u2019s disease; trichorrhexis invaginata (Bamboo hair), congenital ichthyosiform erythroderma and the atopic diathesis. A histopathologic study. Arch Dermatol. 1964;89:46\u201354. https:\/\/doi.org\/10.1001\/archderm.1964.01590250052010.","journal-title":"Arch Dermatol"},{"issue":"4","key":"999_CR3","doi-asserted-by":"publisher","first-page":"WD01-2","DOI":"10.7860\/JCDR\/2016\/18200.7655","volume":"10","author":"SP Jain","year":"2016","unstructured":"Jain\u00a0SP, Jain\u00a0PA, Pandey\u00a0N. The arid melancholy-netherton syndrome with protein energy malnutrition. J\u00a0Clin Diagn Res. 2016;10(4):WD01\u20112. https:\/\/doi.org\/10.7860\/JCDR\/2016\/18200.7655.","journal-title":"J Clin Diagn Res"},{"issue":"3","key":"999_CR4","first-page":"353","volume":"27","author":"SG Bilgili","year":"2016","unstructured":"Bilgili\u00a0SG, Karadag\u00a0AS, Calka\u00a0O, Onder\u00a0S, Bayram\u00a0I. Ichthyosis linearis circumflexa: Not always a part of Netherton syndrome. Genet Couns. 2016;27(3):353\u20136.","journal-title":"Genet Couns"},{"issue":"9","key":"999_CR5","doi-asserted-by":"publisher","first-page":"645259","DOI":"10.3389\/fped.2021.645259","volume":"10","author":"F Barbati","year":"2021","unstructured":"Barbati\u00a0F, Giovannini\u00a0M, Oranges\u00a0T, Lodi\u00a0L, Barni\u00a0S, Novembre\u00a0E, Baldo\u00a0E, Cristofolini\u00a0M, Stagi\u00a0S, Ricci\u00a0S, Mori\u00a0F, Filippeschi\u00a0C, Azzari\u00a0C, Indolfi\u00a0G. Netherton syndrome in children: Management and future perspectives. Front Pediatr. 2021;10(9):645259. https:\/\/doi.org\/10.3389\/fped.2021.645259.","journal-title":"Front Pediatr"},{"issue":"2","key":"999_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1525-1470.1992.tb01231.x","volume":"9","author":"BR Krafchik","year":"1992","unstructured":"Krafchik\u00a0BR. What syndrome is this? Netherton syndrome. Pediatr Dermatol. 1992;9(2):157\u201360. https:\/\/doi.org\/10.1111\/j.1525-1470.1992.tb01231.x.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"999_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000257290","volume":"98","author":"M Comel","year":"1949","unstructured":"Comel\u00a0M. Ichthyosis linearis circumflexa. Dermatologica. 1949;98(3):133\u20136.","journal-title":"Dermatologica"},{"issue":"4","key":"999_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/archderm.1958.01560100059009","volume":"78","author":"EW Netherton","year":"1958","unstructured":"Netherton\u00a0EW. A unique case of trichorrhexis nodosa; bamboo hairs. AMA Arch Derm. 1958;78(4):483\u20137. https:\/\/doi.org\/10.1001\/archderm.1958.01560100059009.","journal-title":"AMA Arch Derm"},{"key":"999_CR9","unstructured":"Orphanet. Comel Netherton syndrome. 2008. https:\/\/www.orpha.net\/consor\/cgi-bin\/Disease_Search.php?lng=EN&data_id=938&Disease_Disease_Search_diseaseType=ORPHA&Disease_Disease_Search_diseaseGroup=634&Disease(s)\/group%20of%20diseases=Comel-Netherton-syndrome&title=Comel-Netherton-syndrome&search=Disease_Search_Simple. Accessed 18 Nov 2020."},{"issue":"2","key":"999_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1046\/j.1523-1747.2002.01603.x","volume":"118","author":"E Bitoun","year":"2002","unstructured":"Bitoun\u00a0E, Chavanas\u00a0S, Irvine\u00a0AD, Lonie\u00a0L, Bodemer\u00a0C, Paradisi\u00a0M, Hamel-Teillac\u00a0D, Ansai\u00a0S, Mitsuhashi\u00a0Y, Ta\u00efeb\u00a0A, de Prost\u00a0Y, Zambruno\u00a0G, Harper\u00a0JI, Hovnanian\u00a0A. Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J\u00a0Invest Dermatol. 2002;118(2):352\u201361. https:\/\/doi.org\/10.1046\/j.1523-1747.2002.01603.x.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"999_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4103\/0974-7753.58561","volume":"1","author":"AD Salodkar","year":"2009","unstructured":"Salodkar\u00a0AD, Choudhary\u00a0SV, Jadwani\u00a0G, Singh\u00a0A. Bamboo hair in Netherton\u2019s syndrome. Int J Trichology. 2009;1(2):143\u20134. https:\/\/doi.org\/10.4103\/0974-7753.58561.","journal-title":"Int J Trichology"},{"issue":"5","key":"999_CR12","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1684\/ejd.2017.3078","volume":"27","author":"ZR Shi","year":"2017","unstructured":"Shi\u00a0ZR, Xu\u00a0M, Tan\u00a0GZ, Wang\u00a0L, Guo\u00a0Q, Tang\u00a0ZQ. A case of Netherton syndrome with mutation in SPINK5 and FLG. Eur J Dermatol. 2017;27(5):536\u20137. https:\/\/doi.org\/10.1684\/ejd.2017.3078.","journal-title":"Eur J Dermatol"},{"issue":"3","key":"999_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4103\/2319-7250.143665","volume":"15","author":"R Kumar","year":"2014","unstructured":"Kumar\u00a0R, Abhinandan\u00a0HB, Mehta\u00a0P, Jain\u00a0S. Netherton\u2019s syndrome. Indian J Paediatr Dermatol. 2014;15(3):120.","journal-title":"Indian J Paediatr Dermatol"},{"issue":"12","key":"999_CR14","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1038\/jid.2010.233","volume":"130","author":"A Briot","year":"2010","unstructured":"Briot\u00a0A, Lacroix\u00a0M, Robin\u00a0A, Steinhoff\u00a0M, Deraison\u00a0C, Hovnanian\u00a0A. Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model. J\u00a0Invest Dermatol. 2010;130(12):2736\u201342. https:\/\/doi.org\/10.1038\/jid.2010.233.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"999_CR15","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1073\/pnas.0607305104","volume":"104","author":"HC Lee","year":"2007","unstructured":"Lee\u00a0HC, Ziegler\u00a0SF. Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB. Proc Natl Acad Sci U S\u00a0A. 2007;104(3):914\u20139. https:\/\/doi.org\/10.1073\/pnas.0607305104.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"999_CR16","first-page":"175","volume":"38","author":"V Kassis","year":"1986","unstructured":"Kassis\u00a0V, Nielsen\u00a0JM, Klem-Thomsen\u00a0H, Dahl-Christensen\u00a0J, Wadskov\u00a0S. Familial Netherton\u2019s disease. Cutis. 1986;38(3):175\u20138.","journal-title":"Cutis"},{"issue":"1","key":"999_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1046\/j.1525-1470.1999.99005.x","volume":"16","author":"S Stryk","year":"1999","unstructured":"Stryk\u00a0S, Siegfried\u00a0EC, Knutsen\u00a0AP. Selective antibody deficiency to bacterial polysaccharide antigens in patients with Netherton syndrome. Pediatr Dermatol. 1999;16(1):19\u201322. https:\/\/doi.org\/10.1046\/j.1525-1470.1999.99005.x.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"999_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1365-4632.2005.02637.x","volume":"45","author":"JD Sun","year":"2006","unstructured":"Sun\u00a0JD, Linden\u00a0KG. Netherton syndrome: a\u00a0case report and review of the literature. Int J Dermatol. 2006;45(6):693\u20137. https:\/\/doi.org\/10.1111\/j.1365-4632.2005.02637.x.","journal-title":"Int J Dermatol"},{"issue":"3","key":"999_CR19","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/bjd.19265","volume":"184","author":"N Bellon","year":"2021","unstructured":"Bellon\u00a0N, Hadj-Rabia\u00a0S, Moulin\u00a0F, Lambe\u00a0C, Lezmi\u00a0G, Charbit-Henrion\u00a0F, Alby\u00a0C, Le Sach\u00e9-de Peufeilhoux\u00a0L, Leclerc-Mercier\u00a0S, Hadchouel\u00a0A, Steffann\u00a0J, Hovnanian\u00a0A, Lapillonne\u00a0A, Bodemer\u00a0C. The challenging management of a\u00a0series of 43 infants with Netherton syndrome: unexpected complications and novel mutations. Br J Dermatol. 2021;184(3):532\u20137. https:\/\/doi.org\/10.1111\/bjd.19265.","journal-title":"Br J Dermatol"},{"issue":"5","key":"999_CR20","first-page":"611","volume":"23","author":"H Boskabadi","year":"2013","unstructured":"Boskabadi\u00a0H, Maamouri\u00a0G, Mafinejad\u00a0S. Netherton syndrome, a\u00a0case report and review of literature. Iran J Pediatr. 2013;23(5):611\u20132.","journal-title":"Iran J Pediatr"},{"issue":"9","key":"999_CR21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s00431-006-0141-0","volume":"165","author":"G Kilic","year":"2006","unstructured":"Kilic\u00a0G, Guler\u00a0N, Ones\u00a0U, Tamay\u00a0Z, Guzel\u00a0P. Netherton syndrome: Report of identical twins presenting with severe atopic dermatitis. Eur J Pediatr. 2006;165(9):594\u20137. https:\/\/doi.org\/10.1007\/s00431-006-0141-0.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"999_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/bjd.16882","volume":"180","author":"J Mazereeuw-Hautier","year":"2019","unstructured":"Mazereeuw-Hautier\u00a0J, Hern\u00e1ndez-Mart\u00edn\u00a0A, O\u2019Toole\u00a0EA, Bygum\u00a0A, Amaro\u00a0C, Aldwin\u00a0M, Audouze\u00a0A, Bodemer\u00a0C, Bourrat\u00a0E, Diociaiuti\u00a0A, Dolenc-Volj\u010d\u00a0M, Dreyfus\u00a0I, El Hachem\u00a0M, Fischer\u00a0J, Ganemo\u00a0A, Gouveia\u00a0C, Gruber\u00a0R, Hadj-Rabia\u00a0S, Hohl\u00a0D, Jonca\u00a0N, Ezzedine\u00a0K, Maier\u00a0D, Malhotra\u00a0R, Rodriguez\u00a0M, Ott\u00a0H, Paige\u00a0DG, Pietrzak\u00a0A, Poot\u00a0F, Schmuth\u00a0M, Sitek\u00a0JC, Steijlen\u00a0P, Wehr\u00a0G, Moreen\u00a0M, Vahlquist\u00a0A, Traupe\u00a0H, Oji\u00a0V. Management of congenital ichthyoses: European guidelines of care, part two. Br J Dermatol. 2019;180(3):484\u201395. https:\/\/doi.org\/10.1111\/bjd.16882.","journal-title":"Br J Dermatol"},{"issue":"5","key":"999_CR23","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1159\/000514699","volume":"7","author":"ME Herz-Ruelas","year":"2021","unstructured":"Herz-Ruelas\u00a0ME, Chavez-Alvarez\u00a0S, Garza-Chapa\u00a0JI, Ocampo-Candiani\u00a0J, Cab-Morales\u00a0VA, Kubelis-L\u00f3pez\u00a0DE. Netherton syndrome: Case report and review of the literature. Skin Appendage Disord. 2021;7(5):346\u201350. https:\/\/doi.org\/10.1159\/000514699.","journal-title":"Skin Appendage Disord"},{"issue":"6","key":"999_CR24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jdcr.2017.07.019","volume":"3","author":"\u00c2 Roda","year":"2017","unstructured":"Roda \u00c2, Mendon\u00e7a-Sanches\u00a0M, Travassos\u00a0AR, Soares-de-Almeida\u00a0L, Metze\u00a0D. Infliximab therapy for Netherton syndrome: A case report. JAAD Case Rep. 2017;3(6):550\u20132. https:\/\/doi.org\/10.1016\/j.jdcr.2017.07.019.","journal-title":"JAAD Case Rep"},{"issue":"2018","key":"999_CR25","doi-asserted-by":"publisher","first-page":"9434916","DOI":"10.1155\/2018\/9434916","volume":"30","author":"AKC Leung","year":"2018","unstructured":"Leung\u00a0AKC, Barankin\u00a0B, Leong\u00a0KF. An 8\u2011year-old child with delayed diagnosis of Netherton syndrome. Case Rep Pediatr. 2018;30(2018):9434916. https:\/\/doi.org\/10.1155\/2018\/9434916.","journal-title":"Case Rep Pediatr"},{"issue":"2","key":"999_CR26","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/bjd.17203","volume":"180","author":"J Mazereeuw-Hautier","year":"2019","unstructured":"Mazereeuw-Hautier\u00a0J, Vahlquist\u00a0A, Traupe\u00a0H, Bygum\u00a0A, Amaro\u00a0C, Aldwin\u00a0M, Audouze\u00a0A, Bodemer\u00a0C, Bourrat\u00a0E, Diociaiuti\u00a0A, Dolenc-Voljc\u00a0M, Dreyfus\u00a0I, El Hachem\u00a0M, Fischer\u00a0J, G\u00e5nemo\u00a0A, Gouveia\u00a0C, Gruber\u00a0R, Hadj-Rabia\u00a0S, Hohl\u00a0D, Jonca\u00a0N, Ezzedine\u00a0K, Maier\u00a0D, Malhotra\u00a0R, Rodriguez\u00a0M, Ott\u00a0H, Paige\u00a0DG, Pietrzak\u00a0A, Poot\u00a0F, Schmuth\u00a0M, Sitek\u00a0JC, Steijlen\u00a0P, Wehr\u00a0G, Moreen\u00a0M, O\u2019Toole\u00a0EA, Oji\u00a0V, Hernandez-Martin\u00a0A. Management of congenital ichthyoses: European guidelines of care, part one. Br J Dermatol. 2019;180(2):272\u201381. https:\/\/doi.org\/10.1111\/bjd.17203.","journal-title":"Br J Dermatol"},{"issue":"6","key":"999_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2165\/11311070-000000000-00000","volume":"10","author":"V Oji","year":"2009","unstructured":"Oji\u00a0V, Traupe\u00a0H. Ichthyosis: clinical manifestations and practical treatment options. Am J Clin Dermatol. 2009;10(6):351\u201364. https:\/\/doi.org\/10.2165\/11311070-000000000-00000.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"999_CR28","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.clindermatol.2008.01.015","volume":"26","author":"JW Fluhr","year":"2008","unstructured":"Fluhr\u00a0JW, Cavallotti\u00a0C, Berardesca\u00a0E. Emollients, moisturizers, and keratolytic agents in psoriasis. Clin Dermatol. 2008;26(4):380\u20136. https:\/\/doi.org\/10.1016\/j.clindermatol.2008.01.015.","journal-title":"Clin Dermatol"},{"issue":"1 Pt 1","key":"999_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/s0091-6749(95)70159-1","volume":"95","author":"DL Smith","year":"1995","unstructured":"Smith\u00a0DL, Smith\u00a0JG, Wong\u00a0SW, deShazo\u00a0RD. Netherton\u2019s syndrome: a\u00a0syndrome of elevated IgE and characteristic skin and hair findings. J\u00a0Allergy Clin Immunol. 1995;95(1 Pt 1):116\u201323. https:\/\/doi.org\/10.1016\/s0091-6749(95)70159-1.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"999_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1525-1470.1994.tb00077.x","volume":"11","author":"MP Seraly","year":"1994","unstructured":"Seraly\u00a0MP, Sheehan\u00a0M, Collins\u00a0M, Mostow\u00a0E. Netherton syndrome revisited. Pediatr Dermatol. 1994;11(1):61\u20134. https:\/\/doi.org\/10.1111\/j.1525-1470.1994.tb00077.x.","journal-title":"Pediatr Dermatol"},{"key":"999_CR31","doi-asserted-by":"publisher","first-page":"561018","DOI":"10.1155\/2012\/561018","volume":"2012","author":"L Uva","year":"2012","unstructured":"Uva\u00a0L, Miguel\u00a0D, Pinheiro\u00a0C, Antunes\u00a0J, Cruz\u00a0D, Ferreira\u00a0J, Filipe\u00a0P. Mechanisms of action of topical corticosteroids in psoriasis. Int J Endocrinol. 2012;2012:561018. https:\/\/doi.org\/10.1155\/2012\/561018.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"999_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1525-1470.2007.00331.x","volume":"24","author":"CP Halverstam","year":"2007","unstructured":"Halverstam\u00a0CP, Vachharajani\u00a0A, Mallory\u00a0SB. Cushing syndrome from percutaneous absorption of 1\u202f% hydrocortisone ointment in Netherton syndrome. Pediatr Dermatol. 2007;24(1):42\u20135. https:\/\/doi.org\/10.1111\/j.1525-1470.2007.00331.x.","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"999_CR33","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2133.1994.tb08558.x","volume":"131","author":"GP Lucker","year":"1994","unstructured":"Lucker\u00a0GP, van de Kerkhof\u00a0PC, van D\u00efjk\u00a0MR, Steijlen\u00a0PM. Effect of topical calcipotriol on congenital ichthyoses. Br J Dermatol. 1994;131(4):546\u201350. https:\/\/doi.org\/10.1111\/j.1365-2133.1994.tb08558.x.","journal-title":"Br J Dermatol"},{"issue":"2","key":"999_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2340\/000155557697101","volume":"76","author":"GP Lucker","year":"1996","unstructured":"Lucker\u00a0GP, Steijen\u00a0PM, Suykerbuyk\u00a0EJ, Kragballe\u00a0K, Brandrup\u00a0F, van de Kerkhof\u00a0PC. Flow-cytometric investigation of epidermal cell characteristics in monogenic disorders of keratinization and their modulation by topical calcipotriol treatment. Acta Derm Venereol. 1996;76(2):97\u2013101. https:\/\/doi.org\/10.2340\/000155557697101.","journal-title":"Acta Derm Venereol"},{"key":"999_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/PHMT.S75834","volume":"7","author":"J Thomas","year":"2016","unstructured":"Thomas\u00a0J, Parimalam\u00a0K. Treating pediatric plaque psoriasis: challenges and solutions. Pediatric Health Med Ther. 2016;7:25\u201338. https:\/\/doi.org\/10.2147\/PHMT.S75834.","journal-title":"Pediatric Health Med Ther"},{"issue":"2","key":"999_CR36","first-page":"115","volume":"14","author":"A Godic","year":"2004","unstructured":"Godic\u00a0A, Dragos\u00a0V. Successful treatment of Netherton\u2019s syndrome with topical calcipotriol. Eur J Dermatol. 2004;14(2):115\u20137.","journal-title":"Eur J Dermatol"},{"key":"999_CR37","volume-title":"StatPearls","author":"OA Safarini","year":"2022","unstructured":"Safarini\u00a0OA, Keshavamurthy\u00a0C, Patel\u00a0P. Calcineurin inhibitors. In: StatPearls. Treasure Island: StatPearls; 2022."},{"issue":"12","key":"999_CR38","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.0906-6705.2004.00269.x","volume":"13","author":"M Grassberger","year":"2004","unstructured":"Grassberger\u00a0M, Steinhoff\u00a0M, Schneider\u00a0D, Luger\u00a0TA. Pimecrolimus\u2014An anti-inflammatory drug targeting the skin. Exp Dermatol. 2004;13(12):721\u201330. https:\/\/doi.org\/10.1111\/j.0906-6705.2004.00269.x.","journal-title":"Exp Dermatol"},{"issue":"6","key":"999_CR39","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/00007691-199512000-00007","volume":"17","author":"AW Thomson","year":"1995","unstructured":"Thomson\u00a0AW, Bonham\u00a0CA, Zeevi\u00a0A. Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. Ther Drug Monit. 1995;17(6):584\u201391. https:\/\/doi.org\/10.1097\/00007691-199512000-00007.","journal-title":"Ther Drug Monit"},{"issue":"3","key":"999_CR40","first-page":"321","volume":"144","author":"C Fabroni","year":"2009","unstructured":"Fabroni\u00a0C, Lotti\u00a0T. Pimecrolimus in dermatology. G\u00a0Ital Dermatol Venereol. 2009;144(3):321\u20135.","journal-title":"G Ital Dermatol Venereol"},{"issue":"Suppl 70","key":"999_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2133.2004.06269.x","volume":"151","author":"A Alomar","year":"2004","unstructured":"Alomar\u00a0A, Berth-Jones\u00a0J, Bos\u00a0JD, Giannetti\u00a0A, Reitamo\u00a0S, Ruzicka\u00a0T, Stalder\u00a0JF, Thestrup-Pedersen\u00a0K. The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol. 2004;151(Suppl 70):3\u201327. https:\/\/doi.org\/10.1111\/j.1365-2133.2004.06269.x.","journal-title":"Br J Dermatol"},{"issue":"3","key":"999_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1365-4632.2006.02956.x","volume":"46","author":"G Bin Saif","year":"2007","unstructured":"Bin Saif\u00a0G, Al-Khenaizan\u00a0S. Netherton syndrome: successful use of topical tacrolimus and pimecrolimus in four siblings. Int J Dermatol. 2007;46(3):290\u20134. https:\/\/doi.org\/10.1111\/j.1365-4632.2006.02956.x.","journal-title":"Int J Dermatol"},{"issue":"6","key":"999_CR43","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamadermatol.2014.4305","volume":"151","author":"DJ Margolis","year":"2015","unstructured":"Margolis\u00a0DJ, Abuabara\u00a0K, Hoffstad\u00a0OJ, Wan\u00a0J, Raimondo\u00a0D, Bilker\u00a0WB. Association between malignancy and topical use of pimecrolimus. JAMA Dermatol. 2015;151(6):594\u20139. https:\/\/doi.org\/10.1001\/jamadermatol.2014.4305.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"999_CR44","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1046\/j.0022-202x.2001.01663.x","volume":"118","author":"N Komatsu","year":"2002","unstructured":"Komatsu\u00a0N, Takata\u00a0M, Otsuki\u00a0N, Ohka\u00a0R, Amano\u00a0O, Takehara\u00a0K, Saijoh\u00a0K. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J\u00a0Invest Dermatol. 2002;118(3):436\u201343. https:\/\/doi.org\/10.1046\/j.0022-202x.2001.01663.x.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"999_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/ijd.13248","volume":"56","author":"NO Tiryakio\u011flu","year":"2017","unstructured":"Tiryakio\u011flu\u00a0NO, \u00d6nal\u00a0Z, Saygili\u00a0SK, \u00d6nal\u00a0H, Ersoy Tunali\u00a0N. Treatment of ichthyosis and hypernatremia in a\u00a0patient with Netherton syndrome with a\u00a0SPINK5 c.153delT mutation using kallikrein inhibiting ointment. Int J Dermatol. 2017;56(1):106\u20138. https:\/\/doi.org\/10.1111\/ijd.13248.","journal-title":"Int J Dermatol"},{"issue":"36","key":"999_CR46","doi-asserted-by":"publisher","first-page":"21886","DOI":"10.1074\/jbc.271.36.21886","volume":"271","author":"CW Franzke","year":"1996","unstructured":"Franzke\u00a0CW, Baici\u00a0A, Bartels\u00a0J, Christophers\u00a0E, Wiedow\u00a0O. Antileukoprotease inhibits stratum corneum chymotryptic enzyme. Evidence for a\u00a0regulative function in desquamation. J\u00a0Biol Chem. 1996;271(36):21886\u201390. https:\/\/doi.org\/10.1074\/jbc.271.36.21886.","journal-title":"J Biol Chem"},{"issue":"3","key":"999_CR47","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/archderm.142.3.396","volume":"142","author":"J Mazereeuw-Hautier","year":"2006","unstructured":"Mazereeuw-Hautier\u00a0J, Cope\u00a0J, Ong\u00a0C, Green\u00a0A, Hovnanian\u00a0A, Harper\u00a0JI. Topical recombinant alpha1-antitrypsin: A\u00a0potential treatment for Netherton syndrome? Arch Dermatol. 2006;142(3):396\u20138. https:\/\/doi.org\/10.1001\/archderm.142.3.396.","journal-title":"Arch Dermatol"},{"issue":"7","key":"999_CR48","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1111\/ijd.12797","volume":"54","author":"R Moutran","year":"2015","unstructured":"Moutran\u00a0R, Maatouk\u00a0I. Development of multiple nevi and lentigines in a\u00a0child with Netherton\u2019s syndrome treated with narrowband ultraviolet B phototherapy. Int J Dermatol. 2015;54(7):e271\u2013e3. https:\/\/doi.org\/10.1111\/ijd.12797.","journal-title":"Int J Dermatol"},{"issue":"4","key":"999_CR49","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3315\/jdcr.2015.1214","volume":"9","author":"R Singer","year":"2015","unstructured":"Singer\u00a0R, \u00c7opur\u00a0M, Y\u00fcksel\u00a0EN, Kocat\u00fcrk\u00a0E, Erhan\u00a0S\u015e. Ichthyosis linearis circumflexa in a\u00a0child. Response to narrowband UVB therapy. J\u00a0Dermatol Case Rep. 2015;9(4):110\u20132. https:\/\/doi.org\/10.3315\/jdcr.2015.1214.","journal-title":"J Dermatol Case Rep"},{"issue":"5","key":"999_CR50","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/s0190-9622(80)80362-8","volume":"2","author":"FS Brown","year":"1980","unstructured":"Brown\u00a0FS, Burnett\u00a0JW, Robinson\u00a0HM Jr.. Cutaneous carcinoma following psoralen and long-wave ultraviolet radiation (PUVA) therapy for psoriasis. J\u00a0Am Acad Dermatol. 1980;2(5):393\u20135. https:\/\/doi.org\/10.1016\/s0190-9622(80)80362-8.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"999_CR51","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1529-8019.2012.01527.x","volume":"26","author":"JJ Digiovanna","year":"2013","unstructured":"Digiovanna\u00a0JJ, Mauro\u00a0T, Milstone\u00a0LM, Schmuth\u00a0M, Toro\u00a0JR. Systemic retinoids in the management of ichthyoses and related skin types. Dermatol Ther. 2013;26(1):26\u201338. https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01527.x.","journal-title":"Dermatol Ther"},{"issue":"Suppl 1","key":"999_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000248867","volume":"175","author":"R Happle","year":"1987","unstructured":"Happle\u00a0R, van de Kerkhof\u00a0PC, Traupe\u00a0H. Retinoids in disorders of keratinization: their use in adults. Dermatologica. 1987;175(Suppl 1):107\u201324. https:\/\/doi.org\/10.1159\/000248867.","journal-title":"Dermatologica"},{"issue":"3","key":"999_CR53","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2165\/00003495-199753030-00003","volume":"53","author":"CE Orfanos","year":"1997","unstructured":"Orfanos\u00a0CE, Zouboulis\u00a0CC, Almond-Roesler\u00a0B, Geilen\u00a0CC. Current use and future potential role of retinoids in dermatology. Drugs. 1997;53(3):358\u201388. https:\/\/doi.org\/10.2165\/00003495-199753030-00003.","journal-title":"Drugs"},{"issue":"4","key":"999_CR54","doi-asserted-by":"publisher","first-page":"604","DOI":"10.24953\/turkjped.2019.04.020","volume":"61","author":"K \u00d6zyurt","year":"2019","unstructured":"\u00d6zyurt\u00a0K, Atasoy\u00a0M, Erta\u015f\u00a0R, Ula\u015f\u00a0Y, Akku\u015f\u00a0MR, Kiraz\u00a0A, Hennies\u00a0HC. Netherton syndrome previously misdiagnosed as hyper IgE syndrome caused by a\u00a0probable mutation in SPINK5 C. Turk J Pediatr. 2019;61(4):604\u20137. https:\/\/doi.org\/10.24953\/turkjped.2019.04.020.","journal-title":"Turk J Pediatr"},{"issue":"6","key":"999_CR55","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s001050050778","volume":"49","author":"S Blaschke","year":"1998","unstructured":"Blaschke\u00a0S, M\u00f6ller\u00a0R, Hausser\u00a0I, Anton-Lamprecht\u00a0I, Paul\u00a0E. Com\u00e8l-Netherton-Syndrom [Com\u00e8l-Netherton syndrome]. Hautarzt. 1998;49(6):499\u2013504. https:\/\/doi.org\/10.1007\/s001050050778.","journal-title":"Hautarzt"},{"issue":"3","key":"999_CR56","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF00456387","volume":"281","author":"I Hausser","year":"1989","unstructured":"Hausser\u00a0I, Anton-Lamprecht\u00a0I, Hartschuh\u00a0W, Petzoldt\u00a0D. Netherton\u2019s syndrome: ultrastructure of the active lesion under retinoid therapy. Arch Dermatol Res. 1989;281(3):165\u201372. https:\/\/doi.org\/10.1007\/BF00456387.","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"999_CR57","first-page":"430","volume":"40","author":"W Hartschuh","year":"1989","unstructured":"Hartschuh\u00a0W, Hausser\u00a0I, Petzoldt\u00a0D. Erfolgreiche Retinoidtherapie des Netherton-Syndroms [Successful retinoid therapy of Netherton syndrome]. Hautarzt. 1989;40(7):430\u20133.","journal-title":"Hautarzt"},{"issue":"3","key":"999_CR58","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jaci.2009.06.009","volume":"124","author":"ED Renner","year":"2009","unstructured":"Renner\u00a0ED, Hartl\u00a0D, Rylaarsdam\u00a0S, Young\u00a0ML, Monaco-Shawver\u00a0L, Kleiner\u00a0G, Markert\u00a0ML, Stiehm\u00a0ER, Belohradsky\u00a0BH, Upton\u00a0MP, Torgerson\u00a0TR, Orange\u00a0JS, Ochs\u00a0HD. Com\u00e8l-Netherton syndrome defined as primary immunodeficiency. J\u00a0Allergy Clin Immunol. 2009;124(3):536\u201343. https:\/\/doi.org\/10.1016\/j.jaci.2009.06.009. Erratum in: J Allergy Clin Immunol. 2009;124(6):1318.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"999_CR59","doi-asserted-by":"publisher","first-page":"426","DOI":"10.2500\/aap.2016.37.3987","volume":"37","author":"FA Bonilla","year":"2016","unstructured":"Bonilla\u00a0FA. Intravenous and subcutaneous immunoglobulin G replacement therapy. Allergy Asthma Proc. 2016;37(6):426\u201331. https:\/\/doi.org\/10.2500\/aap.2016.37.3987.","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"999_CR60","doi-asserted-by":"publisher","first-page":"e222","DOI":"10.1111\/pde.12856","volume":"33","author":"AM Small","year":"2016","unstructured":"Small\u00a0AM, Cordoro\u00a0KM. Netherton syndrome mimicking pustular psoriasis: Clinical implications and response to intravenous immunoglobulin. Pediatr Dermatol. 2016;33(3):e222\u2013e3. https:\/\/doi.org\/10.1111\/pde.12856.","journal-title":"Pediatr Dermatol"},{"key":"999_CR61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/1346-8138.16253","volume":"49","author":"J Wang","year":"2022","unstructured":"Wang\u00a0J, Yu\u00a0L, Zhang\u00a0S, Wang\u00a0C, Li\u00a0Z, Li\u00a0M, et\u00a0al. Successful treatment of Netherton syndrome with dupilumab: A case report and review of the literature. J\u00a0Dermatol. 2022;49:165\u20137. https:\/\/doi.org\/10.1111\/1346-8138.16253.","journal-title":"J Dermatol"},{"issue":"2","key":"999_CR62","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1111\/jdv.16883","volume":"35","author":"K S\u00fc\u00dfmuth","year":"2021","unstructured":"S\u00fc\u00dfmuth\u00a0K, Traupe\u00a0H, Loser\u00a0K, St\u00e4nder\u00a0S, Kessel\u00a0C, Wittkowski\u00a0H, Oji\u00a0V. Response to dupilumab in two children with Netherton syndrome: Improvement of pruritus and scaling. J\u00a0Eur Acad Dermatol Venereol. 2021;35(2):e152\u2013e5. https:\/\/doi.org\/10.1111\/jdv.16883.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"999_CR63","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/ced.14317","volume":"45","author":"TH Andreasen","year":"2020","unstructured":"Andreasen\u00a0TH, Karstensen\u00a0HG, Duno\u00a0M, Lei\u00a0U, Zachariae\u00a0C, Thyssen\u00a0JP. Successful treatment with dupilumab of an adult with Netherton syndrome. Clin Exp Dermatol. 2020;45(7):915\u20137. https:\/\/doi.org\/10.1111\/ced.14317.","journal-title":"Clin Exp Dermatol"},{"key":"999_CR64","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/children9030310","volume":"9","author":"Y Inaba","year":"2022","unstructured":"Inaba\u00a0Y, Kanazawa\u00a0N, Muraoka\u00a0K, Yariyama\u00a0A, Kawaguchi\u00a0A, Kunimoto\u00a0K, Kaminaka\u00a0C, Yamamoto\u00a0Y, Tsujioka\u00a0K, Yoshida\u00a0A, et\u00a0al. Dupilumab improves pruritus in Netherton syndrome: a case study. Children. 2022;9:310. https:\/\/doi.org\/10.3390\/children9030310.","journal-title":"Children"},{"issue":"2","key":"999_CR65","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jdermsci.2021.03.003","volume":"102","author":"C Murase","year":"2021","unstructured":"Murase\u00a0C, Takeichi\u00a0T, Taki\u00a0T, Yoshikawa\u00a0T, Suzuki\u00a0A, Ogi\u00a0T, Suga\u00a0Y, Akiyama\u00a0M. Successful dupilumab treatment for ichthyotic and atopic features of Netherton syndrome. J\u00a0Dermatol Sci. 2021;102(2):126\u20139. https:\/\/doi.org\/10.1016\/j.jdermsci.2021.03.003.","journal-title":"J Dermatol Sci"},{"issue":"3","key":"999_CR66","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1001\/jamadermatol.2019.4608","volume":"156","author":"AB Steuer","year":"2020","unstructured":"Steuer\u00a0AB, Cohen\u00a0DE. Treatment of Netherton syndrome with dupilumab. JAMA Dermatol. 2020;156(3):350\u20131. https:\/\/doi.org\/10.1001\/jamadermatol.2019.4608.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"999_CR67","doi-asserted-by":"publisher","first-page":"97","DOI":"10.18176\/jiaci.0682","volume":"32","author":"FJ Mu\u00f1oz-Bellido","year":"2022","unstructured":"Mu\u00f1oz-Bellido\u00a0FJ, Moreno\u00a0E, D\u00e1vila\u00a0I. Dupilumab: a review of present indications and off-label uses. J\u00a0Investig Allergol Clin Immunol. 2022;32(2):97\u2013115. https:\/\/doi.org\/10.18176\/jiaci.0682.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"999_CR68","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/all.13954","volume":"75","author":"T Bieber","year":"2020","unstructured":"Bieber\u00a0T. Interleukin-13: targeting an underestimated cytokine in atopic dermatitis. Allergy. 2020;75:54\u201362.","journal-title":"Allergy"},{"issue":"4","key":"999_CR69","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jamadermatol.2020.0079","volume":"156","author":"E Guttman-Yassky","year":"2020","unstructured":"Guttman-Yassky\u00a0E, Blauvelt\u00a0A, Eichenfield\u00a0LF, Paller\u00a0AS, Armstrong\u00a0AW, Drew\u00a0J, Gopalan\u00a0R, Simpson\u00a0EL. Efficacy and safety of lebrikizumab, a\u00a0high-affinity interleukin 13 inhibitor, in adults with moderate to severe atopic dermatitis: A phase 2b randomized clinical trial. JAMA Dermatol. 2020;156(4):411\u201320. https:\/\/doi.org\/10.1001\/jamadermatol.2020.0079.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"999_CR70","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jaci.2018.05.029","volume":"143","author":"A Wollenberg","year":"2019","unstructured":"Wollenberg\u00a0A, Howell\u00a0MD, Guttman-Yassky\u00a0E, Silverberg\u00a0JI, Kell\u00a0C, Ranade\u00a0K, Moate\u00a0R, van der Merwe\u00a0R. Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb. J\u00a0Allergy Clin Immunol. 2019;143(1):135\u201341. https:\/\/doi.org\/10.1016\/j.jaci.2018.05.029.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"999_CR71","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1001\/jamadermatol.2020.1019","volume":"156","author":"I Luchsinger","year":"2020","unstructured":"Luchsinger\u00a0I, Kn\u00f6pfel\u00a0N, Theiler\u00a0M, Bonnet des Claustres\u00a0M, Barbieux\u00a0C, Schwieger-Briel\u00a0A, Brunner\u00a0C, Donghi\u00a0D, Buettcher\u00a0M, Meier-Schiesser\u00a0B, Hovnanian\u00a0A, Weibel\u00a0L. Secukinumab therapy for Netherton syndrome. JAMA Dermatol. 2020;156(8):907\u201311. https:\/\/doi.org\/10.1001\/jamadermatol.2020.1019.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"999_CR72","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/bjd.18892","volume":"183","author":"S Volc","year":"2020","unstructured":"Volc\u00a0S, Maier\u00a0L, Gritsch\u00a0A, Aichelburg\u00a0MC, Volc-Platzer\u00a0B. Successful treatment of Netherton syndrome with ustekinumab in a\u00a015-year-old girl. Br J Dermatol. 2020;183(1):165\u20137. https:\/\/doi.org\/10.1111\/bjd.18892.","journal-title":"Br J Dermatol"},{"issue":"9","key":"999_CR73","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1038\/jid.2011.124","volume":"131","author":"L Fontao","year":"2011","unstructured":"Fontao\u00a0L, Laffitte\u00a0E, Briot\u00a0A, Kaya\u00a0G, Roux-Lombard\u00a0P, Fraitag\u00a0S, Hovnanian\u00a0AA, Saurat\u00a0JH. Infliximab infusions for Netherton syndrome: sustained clinical improvement correlates with a\u00a0reduction of thymic stromal lymphopoietin levels in the skin. J\u00a0Invest Dermatol. 2011;131(9):1947\u201350. https:\/\/doi.org\/10.1038\/jid.2011.124.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"999_CR74","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/08923973.2015.1115518","volume":"38","author":"AD Yalcin","year":"2016","unstructured":"Yalcin\u00a0AD. A case of netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels. Immunopharmacol Immunotoxicol. 2016;38(2):162\u20136. https:\/\/doi.org\/10.3109\/08923973.2015.1115518.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"11","key":"999_CR75","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/21678707.2020.1857724","volume":"8","author":"E Petrova","year":"2020","unstructured":"Petrova\u00a0E, Hovnanian\u00a0A. Advances in understanding of Netherton syndrome and therapeutic implications. Expert Opin Orphan Drugs. 2020;8(11):455\u201387. https:\/\/doi.org\/10.1080\/21678707.2020.1857724.","journal-title":"Expert Opin Orphan Drugs"},{"issue":"4","key":"999_CR76","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1056\/NEJMoa1314258","volume":"371","author":"RG Langley","year":"2014","unstructured":"Langley\u00a0RG, Elewski\u00a0BE, Lebwohl\u00a0M, Reich\u00a0K, Griffiths\u00a0CE, Papp\u00a0K, Puig\u00a0L, Nakagawa\u00a0H, Spelman\u00a0L, Sigurgeirsson\u00a0B, Rivas\u00a0E, Tsai\u00a0TF, Wasel\u00a0N, Tyring\u00a0S, Salko\u00a0T, Hampele\u00a0I, Notter\u00a0M, Karpov\u00a0A, Helou\u00a0S, Papavassilis\u00a0C. Secukinumab in plaque psoriasis\u2014Results of two phase 3 trials. N\u00a0Engl J Med. 2014;371(4):326\u201338. https:\/\/doi.org\/10.1056\/NEJMoa1314258.","journal-title":"N Engl J Med"},{"issue":"4","key":"999_CR77","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/bjd.15706","volume":"177","author":"R Bissonnette","year":"2017","unstructured":"Bissonnette\u00a0R, Luger\u00a0T, Tha\u00e7i\u00a0D, Toth\u00a0D, Messina\u00a0I, You\u00a0R, Guana\u00a0A, Fox\u00a0T, Papavassilis\u00a0C, Gilloteau\u00a0I, Mrowietz\u00a0U. Secukinumab sustains good efficacy and favourable safety in moderate-to-severe psoriasis after up to 3\u00a0years of treatment: results from a\u00a0double-blind extension study. Br J Dermatol. 2017;177(4):1033\u201342. https:\/\/doi.org\/10.1111\/bjd.15706.","journal-title":"Br J Dermatol"},{"issue":"6","key":"999_CR78","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jdcr.2020.04.025","volume":"6","author":"SK Blanchard","year":"2020","unstructured":"Blanchard\u00a0SK, Prose\u00a0NS. Successful use of secukinumab in Netherton syndrome. JAAD Case Rep. 2020;6(6):577\u20138. https:\/\/doi.org\/10.1016\/j.jdcr.2020.04.025.","journal-title":"JAAD Case Rep"},{"issue":"5","key":"999_CR79","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jaad.2020.07.054","volume":"84","author":"C Barbieux","year":"2021","unstructured":"Barbieux\u00a0C, Bonnet des Claustres\u00a0M, de la Brassinne\u00a0M, Bricteux\u00a0G, Bagot\u00a0M, Bourrat\u00a0E, Hovnanian\u00a0A. Duality of Netherton syndrome manifestations and response to ixekizumab. J\u00a0Am Acad Dermatol. 2021;84(5):1476\u201380. https:\/\/doi.org\/10.1016\/j.jaad.2020.07.054.","journal-title":"J Am Acad Dermatol"},{"key":"999_CR80","doi-asserted-by":"publisher","first-page":"212570","DOI":"10.7573\/dic.212570","volume":"8","author":"AC Foulkes","year":"2019","unstructured":"Foulkes\u00a0AC, Warren\u00a0RB. Brodalumab in psoriasis: evidence to date and clinical potential. Drugs Context. 2019;8:212570. https:\/\/doi.org\/10.7573\/dic.212570.","journal-title":"Drugs Context"},{"key":"999_CR81","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/09546634.2018.1427205","volume":"29","author":"L Sawyer","year":"2018","unstructured":"Sawyer\u00a0L, Fotheringham\u00a0I, Wright\u00a0E, et al. The comparative efficacy of brodalumab in patients with moderate-to-severe psoriasis: a\u00a0systematic literature review and network meta-analysis. J\u00a0Dermatolog Treat. 2018;29:557\u201368.","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"999_CR82","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1440-0960.2011.00853.x","volume":"53","author":"L Young","year":"2012","unstructured":"Young\u00a0L, Czarnecki\u00a0D. The rapid onset of multiple squamous cell carcinomas in two patients commenced on ustekinumab as treatment of psoriasis. Australas J Dermatol. 2012;53(1):57\u201360. https:\/\/doi.org\/10.1111\/j.1440-0960.2011.00853.x.","journal-title":"Australas J Dermatol"},{"issue":"16","key":"999_CR83","doi-asserted-by":"publisher","first-page":"9479","DOI":"10.3390\/ijms23169479","volume":"23","author":"H Iznardo","year":"2022","unstructured":"Iznardo\u00a0H, Puig\u00a0L. IL\u20111 family cytokines in inflammatory dermatoses: Pathogenetic role and potential therapeutic implications. Int J Mol Sci. 2022;23(16):9479. https:\/\/doi.org\/10.3390\/ijms23169479.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"999_CR84","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","volume":"281","author":"CA Dinarello","year":"2018","unstructured":"Dinarello\u00a0CA. Overview of the IL\u20111 family in innate inflammation and acquired immunity. Immunol Rev. 2018;281(1):8\u201327. https:\/\/doi.org\/10.1111\/imr.12621.","journal-title":"Immunol Rev"},{"issue":"8","key":"999_CR85","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrd3800","volume":"11","author":"CA Dinarello","year":"2012","unstructured":"Dinarello\u00a0CA, Simon\u00a0A, van der Meer\u00a0JW. Treating inflammation by blocking interleukin\u20111 in a\u00a0broad spectrum of diseases. Nat Rev Drug Discov. 2012;11(8):633\u201352. https:\/\/doi.org\/10.1038\/nrd3800.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"999_CR86","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jaad.2013.09.044","volume":"70","author":"KS Leslie","year":"2014","unstructured":"Leslie\u00a0KS, Tripathi\u00a0SV, Nguyen\u00a0TV, Pauli\u00a0M, Rosenblum\u00a0MD. An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa. J\u00a0Am Acad Dermatol. 2014;70(2):243\u201351. https:\/\/doi.org\/10.1016\/j.jaad.2013.09.044.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"999_CR87","doi-asserted-by":"publisher","first-page":"66","DOI":"10.7326\/0003-4819-153-1-201007060-00030","volume":"153","author":"M Viguier","year":"2010","unstructured":"Viguier\u00a0M, Guigue\u00a0P, Pag\u00e8s\u00a0C, Smahi\u00a0A, Bachelez\u00a0H. Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist Anakinra: Lack of correlation with IL1RN mutations. Ann Intern Med. 2010;153(1):66\u20137. https:\/\/doi.org\/10.7326\/0003-4819-153-1-201007060-00030.","journal-title":"Ann Intern Med"},{"issue":"26","key":"999_CR88","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa2111563","volume":"385","author":"H Bachelez","year":"2021","unstructured":"Bachelez\u00a0H, Choon\u00a0SE, Marrakchi\u00a0S, Burden\u00a0AD, Tsai\u00a0TF, Morita\u00a0A, Navarini\u00a0AA, Zheng\u00a0M, Xu\u00a0J, Turki\u00a0H, Anadkat\u00a0MJ, Rajeswari\u00a0S, Hua\u00a0H, Vulcu\u00a0SD, Hall\u00a0D, Tetzlaff\u00a0K, Thoma\u00a0C, Lebwohl\u00a0MG. Trial investigators. Trial of spesolimab for generalized pustular psoriasis. N\u00a0Engl J Med. 2021;385(26):2431\u201340. https:\/\/doi.org\/10.1056\/NEJMoa2111563.","journal-title":"N Engl J Med"},{"issue":"7","key":"999_CR89","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1080\/09546634.2022.2089335","volume":"33","author":"CO Ma\u00e7\u00e3es","year":"2022","unstructured":"Ma\u00e7\u00e3es\u00a0CO, L\u00e9\u00a0AM, Torres\u00a0T. Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors. J\u00a0Dermatolog Treat. 2022;33(7):2911\u20138. https:\/\/doi.org\/10.1080\/09546634.2022.2089335.","journal-title":"J Dermatolog Treat"},{"key":"999_CR90","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000484406","volume":"233","author":"U Nygaard","year":"2018","unstructured":"Nygaard\u00a0U, Vestergaard\u00a0C, Deleuran\u00a0M. Emerging treatment options in atopic dermatitis: systemic therapies. Dermatology. 2018;233:344\u201357.","journal-title":"Dermatology"},{"issue":"6","key":"999_CR91","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jcf.2017.06.012","volume":"16","author":"S Trend","year":"2017","unstructured":"Trend\u00a0S, Fonceca\u00a0AM, Ditcham\u00a0WG, Kicic\u00a0A, Cf\u00a0A. The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in pseudomonas aeruginosa-infected airways. J\u00a0Cyst Fibros. 2017;16(6):663\u201370. https:\/\/doi.org\/10.1016\/j.jcf.2017.06.012.","journal-title":"J Cyst Fibros"},{"key":"999_CR92","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fmed.2017.00094","volume":"4","author":"P Zhvania","year":"2017","unstructured":"Zhvania\u00a0P, Hoyle\u00a0NS, Nadareishvili\u00a0L, Nizharadze\u00a0D, Kutateladze\u00a0M. Phage therapy in a\u00a016-year-old boy with Netherton syndrome. Front Med (Lausanne). 2017;4:94. https:\/\/doi.org\/10.3389\/fmed.2017.00094.","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"999_CR93","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.3390\/v7082845","volume":"7","author":"J Majewska","year":"2015","unstructured":"Majewska\u00a0J, Beta\u00a0W, Lecion\u00a0D, Hodyra-Stefaniak\u00a0K, K\u0142opot\u00a0A, Ka\u017amierczak\u00a0Z, Miernikiewicz\u00a0P, Piotrowicz\u00a0A, Ciekot\u00a0J, Owczarek\u00a0B, Kopciuch\u00a0A, Wojtyna\u00a0K, Harhala\u00a0M, M\u0105kosa\u00a0M, D\u0105browska\u00a0K. Oral application of T4 phage induces weak antibody production in the gut and in the blood. Viruses. 2015;7(8):4783\u201399. https:\/\/doi.org\/10.3390\/v7082845.","journal-title":"Viruses"},{"issue":"5","key":"999_CR94","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2217\/fmb.15.28","volume":"10","author":"EM Kutter","year":"2015","unstructured":"Kutter\u00a0EM, Kuhl\u00a0SJ, Abedon\u00a0ST. Re-establishing a\u00a0place for phage therapy in western medicine. Future Microbiol. 2015;10(5):685\u20138. https:\/\/doi.org\/10.2217\/fmb.15.28.","journal-title":"Future Microbiol"},{"issue":"4","key":"999_CR95","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1089\/humc.2013.195","volume":"24","author":"WL Di","year":"2013","unstructured":"Di\u00a0WL, Mellerio\u00a0JE, Bernadis\u00a0C, Harper\u00a0J, Abdul-Wahab\u00a0A, Ghani\u00a0S, Chan\u00a0L, Martinez-Queipo\u00a0M, Hara\u00a0H, McNicol\u00a0AM, Farzaneh\u00a0F, McGrath\u00a0J, Thrasher\u00a0A, Qasim\u00a0W. Phase I study protocol for ex vivo lentiviral gene therapy for the inherited skin disease, Netherton syndrome. Hum Gene Ther Clin Dev. 2013;24(4):182\u201390. https:\/\/doi.org\/10.1089\/humc.2013.195.","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"3","key":"999_CR96","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jdermsci.2010.12.004","volume":"61","author":"D Roedl","year":"2011","unstructured":"Roedl\u00a0D, Oji\u00a0V, Buters\u00a0JT, Behrendt\u00a0H, Braun-Falco\u00a0M. rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients. J\u00a0Dermatol Sci. 2011;61(3):194\u20138. https:\/\/doi.org\/10.1016\/j.jdermsci.2010.12.004.","journal-title":"J Dermatol Sci"},{"issue":"12","key":"999_CR97","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/nm1504","volume":"12","author":"F Mavilio","year":"2006","unstructured":"Mavilio\u00a0F, Pellegrini\u00a0G, Ferrari\u00a0S, Di Nunzio\u00a0F, Di Iorio\u00a0E, Recchia\u00a0A, Maruggi\u00a0G, Ferrari\u00a0G, Provasi\u00a0E, Bonini\u00a0C, Capurro\u00a0S, Conti\u00a0A, Magnoni\u00a0C, Giannetti\u00a0A, De Luca\u00a0M. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med. 2006;12(12):1397\u2013402. https:\/\/doi.org\/10.1038\/nm1504.","journal-title":"Nat Med"},{"issue":"3","key":"999_CR98","first-page":"237","volume":"12","author":"C Stoll","year":"2001","unstructured":"Stoll\u00a0C, Alembik\u00a0Y, Tchomakov\u00a0D, Messer\u00a0J, Heid\u00a0E, Boehm\u00a0N, Calvas\u00a0P, Hovnanian\u00a0A. Severe hypernatremic dehydration in an infant with Netherton syndrome. Genet Couns. 2001;12(3):237\u201343.","journal-title":"Genet Couns"},{"issue":"4","key":"999_CR99","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1111\/pde.12076","volume":"30","author":"A Diociaiuti","year":"2013","unstructured":"Diociaiuti\u00a0A, Castiglia\u00a0D, Fortugno\u00a0P, Bartuli\u00a0A, Pascucci\u00a0M, Zambruno\u00a0G, El Hachem\u00a0M. Lethal Netherton syndrome due to homozygous p.Arg371X mutation in SPINK5. Pediatr Dermatol. 2013;30(4):e65\u2013e7. https:\/\/doi.org\/10.1111\/pde.12076.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"999_CR100","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s004310050789","volume":"157","author":"M Pohl","year":"1998","unstructured":"Pohl\u00a0M, Zimmerhackl\u00a0LB, Hausser\u00a0I, Ludwig\u00a0H, Hildebrandt\u00a0F, Gordjani\u00a0N, Sutor\u00a0AH, Anton-Lamprecht\u00a0I, Brandis\u00a0M. Acute bilateral renal vein thrombosis complicating Netherton syndrome. Eur J Pediatr. 1998;157(2):157\u201360. https:\/\/doi.org\/10.1007\/s004310050789.","journal-title":"Eur J Pediatr"},{"issue":"4","key":"999_CR101","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.5546\/aap.2018.eng.e609","volume":"116","author":"E Okulu","year":"2018","unstructured":"Okulu\u00a0E, Tunc\u00a0G, Erdeve\u00a0O, Mumcu\u00a0Y, Atasay\u00a0B, Ince\u00a0E, Arsan\u00a0S. Netherton syndrome: A neonatal case with respiratory insufficiency. Arch Argent Pediatr. 2018;116(4):e609\u2013e11. https:\/\/doi.org\/10.5546\/aap.2018.eng.e609.","journal-title":"Arch Argent Pediatr"},{"issue":"3","key":"999_CR102","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1525-1470.2008.00685.x","volume":"25","author":"CA Macknet","year":"2008","unstructured":"Macknet\u00a0CA, Morkos\u00a0A, Job\u00a0L, Garberoglio\u00a0MC, Clark\u00a0RD, Macknet\u00a0KD Jr, Peverini\u00a0RL. An infant with Netherton syndrome and persistent pulmonary hypertension requiring extracorporeal membrane oxygenation. Pediatr Dermatol. 2008;25(3):368\u201372. https:\/\/doi.org\/10.1111\/j.1525-1470.2008.00685.x.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"999_CR103","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1684\/ejd.2016.2761","volume":"26","author":"P Machet","year":"2016","unstructured":"Machet\u00a0P, Bodemer\u00a0C, Lorette\u00a0G, Fraitag\u00a0S, Raynaud\u00a0M, Willot\u00a0S, Maruani\u00a0A. Exocrine pancreatic insufficiency in a\u00a0child with Netherton syndrome. Eur J Dermatol. 2016;26(3):311\u20132. https:\/\/doi.org\/10.1684\/ejd.2016.2761.","journal-title":"Eur J Dermatol"},{"issue":"11","key":"999_CR104","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.jpedsurg.2005.07.058","volume":"40","author":"K S\u00f6reide","year":"2005","unstructured":"S\u00f6reide\u00a0K, S\u00f6iland\u00a0H, K\u00f6rner\u00a0H, Haga\u00a0H, S\u00f6reide\u00a0JA. Acute pancreatitis in a\u00a0young girl with the Netherton syndrome. J\u00a0Pediatr Surg. 2005;40(11):e69\u2013e72. https:\/\/doi.org\/10.1016\/j.jpedsurg.2005.07.058.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"999_CR105","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.aller.2011.07.005","volume":"40","author":"S Pastore","year":"2012","unstructured":"Pastore\u00a0S, Gorlato\u00a0G, Berti\u00a0I, Barbi\u00a0E, Ventura\u00a0A. Successful induction of oral tolerance in Netherton syndrome. Allergol Immunopathol (Madr). 2012;40(5):316\u20137. https:\/\/doi.org\/10.1016\/j.aller.2011.07.005.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"4","key":"999_CR106","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jaci.2014.07.008","volume":"134","author":"K Hannula-Jouppi","year":"2014","unstructured":"Hannula-Jouppi\u00a0K, Laasanen\u00a0SL, Heikkil\u00e4\u00a0H, Tuomiranta\u00a0M, Tuomi\u00a0ML, Hilvo\u00a0S, Kluger\u00a0N, Kivirikko\u00a0S, Hovnanian\u00a0A, M\u00e4kinen-Kiljunen\u00a0S, Ranki\u00a0A. IgE allergen component-based profiling and atopic manifestations in patients with Netherton syndrome. J\u00a0Allergy Clin Immunol. 2014;134(4):985\u20138. https:\/\/doi.org\/10.1016\/j.jaci.2014.07.008.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"999_CR107","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1440-0960.1982.tb00235.x","volume":"23","author":"D Greig","year":"1982","unstructured":"Greig\u00a0D, Wishart\u00a0J. Growth abnormality in Netherton\u2019s syndrome. Australas J Dermatol. 1982;23(1):27\u201331. https:\/\/doi.org\/10.1111\/j.1440-0960.1982.tb00235.x.","journal-title":"Australas J Dermatol"},{"issue":"1","key":"999_CR108","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/pde.12220","volume":"31","author":"BK Ayd\u0131n","year":"2014","unstructured":"Ayd\u0131n\u00a0BK, Ba\u015f\u00a0F, Tamay\u00a0Z, K\u0131l\u0131\u00e7\u00a0G, S\u00fcleyman\u00a0A, Bundak\u00a0R, Saka\u00a0N, \u00d6zkaya\u00a0E, G\u00fcler\u00a0N, Darendeliler\u00a0F. Netherton syndrome associated with growth hormone deficiency. Pediatr Dermatol. 2014;31(1):90\u20134. https:\/\/doi.org\/10.1111\/pde.12220.","journal-title":"Pediatr Dermatol"},{"key":"999_CR109","first-page":"376","volume":"99","author":"S Brown","year":"2017","unstructured":"Brown\u00a0S, De La Cerda Stephen\u00a0AMD. Netherton syndrome in association with Vitamin D deficiency. Cutis. 2017;99:376\u20137.","journal-title":"Cutis"},{"issue":"3","key":"999_CR110","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.clinthera.2019.01.010","volume":"41","author":"L Galli","year":"2019","unstructured":"Galli\u00a0L, Venturini\u00a0E, Bassi\u00a0A, Gattinara\u00a0GC, Chiappini\u00a0E, Defilippi\u00a0C, Diociaiuti\u00a0A, Esposito\u00a0S, Garazzino\u00a0S, Giannattasio\u00a0A, Krzysztofiak\u00a0A, Latorre\u00a0S, Lo Vecchio\u00a0A, Marchisio\u00a0P, Montagnani\u00a0C, Nicolini\u00a0G, Novelli\u00a0A, Rossolini\u00a0GM, Tersigni\u00a0C, Villani\u00a0A, El Hachem\u00a0M, Neri\u00a0I. Common community-acquired bacterial skin and soft-tissue infections in children: An intersociety consensus on impetigo, abscess, and cellulitis treatment. Clin Ther. 2019;41(3):532\u2013551.e1. https:\/\/doi.org\/10.1016\/j.clinthera.2019.01.010.","journal-title":"Clin Ther"},{"issue":"13\u201314","key":"999_CR111","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1177\/1359105318790052","volume":"25","author":"JJ Versteegh","year":"2020","unstructured":"Versteegh\u00a0JJ, Dulfer\u00a0K, Stuvel\u00a0K, Pasmans\u00a0SG, Utens\u00a0EM. Netherton syndrome; neuropsychological and psychosocial functioning of child and adult patients and their parents. J\u00a0Health Psychol. 2020;25(13\u201314):2296\u2013316. https:\/\/doi.org\/10.1177\/1359105318790052.","journal-title":"J Health Psychol"},{"issue":"3","key":"999_CR112","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1046\/j.1365-2133.2002.04625.x","volume":"146","author":"FB M\u00fcller","year":"2002","unstructured":"M\u00fcller\u00a0FB, Hausser\u00a0I, Berg\u00a0D, Casper\u00a0C, Maiwald\u00a0R, Jung\u00a0A, Jung\u00a0H, Korge\u00a0BP. Genetic analysis of a\u00a0severe case of Netherton syndrome and application for prenatal testing. Br J Dermatol. 2002;146(3):495\u20139. https:\/\/doi.org\/10.1046\/j.1365-2133.2002.04625.x.","journal-title":"Br J Dermatol"},{"issue":"1","key":"999_CR113","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/humupd\/8.1.11","volume":"8","author":"K Sermon","year":"2002","unstructured":"Sermon\u00a0K. Current concepts in preimplantation genetic diagnosis (PGD): a\u00a0molecular biologist\u2019s view. Hum Reprod Update. 2002;8(1):11\u201320. https:\/\/doi.org\/10.1093\/humupd\/8.1.11.","journal-title":"Hum Reprod Update"},{"issue":"7","key":"999_CR114","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10815-011-9568-y","volume":"28","author":"B Bingol","year":"2011","unstructured":"Bingol\u00a0B, Tasdemir\u00a0S, Gunenc\u00a0Z, Abike\u00a0F, Esenkaya\u00a0S, Tavukcuoglu\u00a0S, Berkil\u00a0H. Prenatal diagnosis of Comel-Netherton syndrome with PGD, case report and review article. J\u00a0Assist Reprod Genet. 2011;28(7):615\u201320. https:\/\/doi.org\/10.1007\/s10815-011-9568-y.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"999_CR115","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.0022-202X.2004.23583.x","volume":"124","author":"A Ishida-Yamamoto","year":"2005","unstructured":"Ishida-Yamamoto\u00a0A, Deraison\u00a0C, Bonnart\u00a0C, Bitoun\u00a0E, Robinson\u00a0R, O\u2019Brien\u00a0TJ, Wakamatsu\u00a0K, Ohtsubo\u00a0S, Takahashi\u00a0H, Hashimoto\u00a0Y, Dopping-Hepenstal\u00a0PJ, McGrath\u00a0JA, Iizuka\u00a0H, Richard\u00a0G, Hovnanian\u00a0A. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum. J\u00a0Invest Dermatol. 2005;124(2):360\u20136. https:\/\/doi.org\/10.1111\/j.0022-202X.2004.23583.x.","journal-title":"J Invest Dermatol"},{"issue":"19","key":"999_CR116","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1093\/hmg\/ddg247","volume":"12","author":"E Bitoun","year":"2003","unstructured":"Bitoun\u00a0E, Micheloni\u00a0A, Lamant\u00a0L, Bonnart\u00a0C, Tartaglia-Polcini\u00a0A, Cobbold\u00a0C, Al Saati\u00a0T, Mariotti\u00a0F, Mazereeuw-Hautier\u00a0J, Boralevi\u00a0F, Hohl\u00a0D, Harper\u00a0J, Bodemer\u00a0C, D\u2019Alessio\u00a0M, Hovnanian\u00a0A. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. Hum Mol Genet. 2003;12(19):2417\u201330. https:\/\/doi.org\/10.1093\/hmg\/ddg247.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"999_CR117","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/pd.247","volume":"22","author":"E Bitoun","year":"2002","unstructured":"Bitoun\u00a0E, Bodemer\u00a0C, Amiel\u00a0J, de Prost\u00a0Y, Stoll\u00a0C, Calvas\u00a0P, Hovnanian\u00a0A. Prenatal diagnosis of a\u00a0lethal form of Netherton syndrome by SPINK5 mutation analysis. Prenat Diagn. 2002;22(2):121\u20136. https:\/\/doi.org\/10.1002\/pd.247.","journal-title":"Prenat Diagn"},{"issue":"3","key":"999_CR118","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1086\/302824","volume":"66","author":"S Chavanas","year":"2000","unstructured":"Chavanas\u00a0S, Garner\u00a0C, Bodemer\u00a0C, Ali\u00a0M, Teillac\u00a0DH, Wilkinson\u00a0J, Bonaf\u00e9\u00a0JL, Paradisi\u00a0M, Kelsell\u00a0DP, Ansai\u00a0S, Mitsuhashi\u00a0Y, Larr\u00e8gue\u00a0M, Leigh\u00a0IM, Harper\u00a0JI, Ta\u00efeb\u00a0A, de Prost\u00a0Y, Cardon\u00a0LR, Hovnanian\u00a0A. Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping. Am J Hum Genet. 2000;66(3):914\u201321. https:\/\/doi.org\/10.1086\/302824.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"999_CR119","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1046\/j.1523-1747.2001.01389.x","volume":"117","author":"E Sprecher","year":"2001","unstructured":"Sprecher\u00a0E, Chavanas\u00a0S, DiGiovanna\u00a0JJ, Amin\u00a0S, Nielsen\u00a0K, Prendiville\u00a0JS, Silverman\u00a0R, Esterly\u00a0NB, Spraker\u00a0MK, Guelig\u00a0E, de Luna\u00a0ML, Williams\u00a0ML, Buehler\u00a0B, Siegfried\u00a0EC, Van Maldergem\u00a0L, Pfendner\u00a0E, Bale\u00a0SJ, Uitto\u00a0J, Hovnanian\u00a0A, Richard\u00a0G. The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. J\u00a0Invest Dermatol. 2001;117(2):179\u201387. https:\/\/doi.org\/10.1046\/j.1523-1747.2001.01389.x.","journal-title":"J Invest Dermatol"},{"issue":"2 Pt 2","key":"999_CR120","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0190-9622(85)70170-3","volume":"13","author":"SL Greene","year":"1985","unstructured":"Greene\u00a0SL, Muller\u00a0SA. Netherton\u2019s syndrome. Report of a\u00a0case and review of the literature. J\u00a0Am Acad Dermatol. 1985;13(2 Pt 2):329\u201337.","journal-title":"J Am Acad Dermatol"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-022-00999-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10354-022-00999-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-022-00999-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T20:55:16Z","timestamp":1693860916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10354-022-00999-y"}},"subtitle":["Presentation of a\u00a0case and an update of therapeutic options","Fallvorstellung und Update zu therapeutischen Optionen"],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":120,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["999"],"URL":"https:\/\/doi.org\/10.1007\/s10354-022-00999-y","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"type":"print","value":"0043-5341"},{"type":"electronic","value":"1563-258X"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"7 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.\u00a0Kordeva, I.\u00a0Batashki, and G.\u00a0Tchernev declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}